Sirolimus demonstrates activity in the primary therapy of acute graft-versus-host disease without systemic glucocorticoids.

MLA

Pidala, Joseph, et al. “Sirolimus Demonstrates Activity in the Primary Therapy of Acute Graft-versus-Host Disease without Systemic Glucocorticoids.” Haematologica, vol. 96, no. 9, Sept. 2011, pp. 1351–56. EBSCOhost, https://doi.org/10.3324/haematol.2011.041236.

APA

Pidala, J., Tomblyn, M., Nishihori, T., Field, T., Ayala, E., Perkins, J., Fernandez, H., Locke, F., Perez, L., Ochoa, J. L., Alsina, M., & Anasetti, C. (2011). Sirolimus demonstrates activity in the primary therapy of acute graft-versus-host disease without systemic glucocorticoids. Haematologica, 96(9), 1351–1356. https://doi.org/10.3324/haematol.2011.041236

Chicago

Pidala, Joseph, Marcie Tomblyn, Taiga Nishihori, Teresa Field, Ernesto Ayala, Janelle Perkins, Hugo Fernandez, et al. 2011. “Sirolimus Demonstrates Activity in the Primary Therapy of Acute Graft-versus-Host Disease without Systemic Glucocorticoids.” Haematologica 96 (9): 1351–56. doi:10.3324/haematol.2011.041236.